Modelling esophageal adenocarcinoma and Barrett's esophagus with patient-derived organoids
Currently, esophageal adenocarcinoma (EAC) research is hindered by a dearth of adequate models to study this disease. Traditional cell line and genetically engineered mouse models are lacking in biological and physiological significance, whilst the inefficiency of patient-derived xenografts limit th...
Saved in:
Published in | Frontiers in molecular biosciences Vol. 11; p. 1382070 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
24.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Currently, esophageal adenocarcinoma (EAC) research is hindered by a dearth of adequate models to study this disease. Traditional cell line and genetically engineered mouse models are lacking in biological and physiological significance, whilst the inefficiency of patient-derived xenografts limit their potential applications. This review describes the landscape of EAC research using patient-derived organoids (PDOs). Here, we detail the methods of establishment and optimization of EAC PDO cultures, as well as current and prospective applications of these models. We further highlight a crucial knowledge gap in the mechanisms of EAC transformation from its precursor lesion, Barrett's esophagus (BE). As such, we also describe the culture requirements of BE PDOs and attempts to model tumorigenesis using PDO models. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Edited by: Farah Ballout, University of Miami Health System, United States Reviewed by: Hemamylammal Sivakumar, The Ohio State University, United States Wassim Abou-Kheir, American University of Beirut, Lebanon Paloma Ordonez Moran, University of Nottingham, United Kingdom |
ISSN: | 2296-889X 2296-889X |
DOI: | 10.3389/fmolb.2024.1382070 |